|
SNX6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.383330E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.641710E-04 |
| Normal-vs-Stage2 |
3.714400E-01 |
| Normal-vs-Stage3 |
6.605800E-01 |
| Normal-vs-Stage4 |
1.778790E-01 |
| Stage1-vs-Stage2 |
1.768350E-01 |
| Stage1-vs-Stage3 |
3.003800E-02 |
| Stage1-vs-Stage4 |
7.879200E-01 |
| Stage2-vs-Stage3 |
6.796800E-01 |
| Stage2-vs-Stage4 |
5.671200E-01 |
| Stage3-vs-Stage4 |
3.605000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.562900E-04 |
| Normal-vs-AfricanAmerican |
6.942400E-02 |
| Normal-vs-Asian |
7.952800E-01 |
| Caucasian-vs-AfricanAmerican |
2.674600E-01 |
| Caucasian-vs-Asian |
3.770600E-01 |
| AfricanAmerican-vs-Asian |
6.703200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.7817E-05 |
| Normal-vs-Female |
5.382000E-01 |
| Male-vs-Female |
4.077100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.781600E-03 |
| Normal-vs-Extreme_Weight |
2.222800E-04 |
| Normal-vs-Obese |
5.718300E-02 |
| Normal-vs-Extreme_Obese |
2.487400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.191400E-01 |
| Normal_Weight-vs-Obese |
3.120600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.780000E-01 |
| Extreme_Weight-vs-Obese |
4.162200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.639000E-01 |
| Obese-vs-Extreme_Obese |
6.699200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.296600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.458400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.236480E-04 |
| Normal-vs-Age(81-100Yrs) |
8.967200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.320000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.725500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.038400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.045900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.281150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.996800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.42590000000865E-05 |
| Normal-VS-Type2 PRCC |
1.616430E-02 |
| Normal-VS-KIRP CIMP |
2.329400E-01 |
| Normal-VS-Unclassified PRCC |
4.190200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.400200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.446100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.894300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.459300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.202200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.958500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.043800E-04 |
| Normal-vs-N1 |
5.165200E-01 |
| Normal-vs-N2 |
4.239100E-04 |
| N0-vs-N1 |
1.399380E-03 |
| N0-vs-N2 |
1.983390E-01 |
| N1-vs-N2 |
2.639700E-02 |
|
|
